Evogene

Find the latest for Evogene company news

Generative AI: The Next Evolution In Product Design And Marketing

In the last few years, generative AI has redefined product design and marketing for businesses looking to stay ahead. In fact, the market for AI in product design is projected to rapidly grow at a rate of 12.1% per year, from $15.84 billion in 2025 to $24.99 billion by 2029.

UNC Charlotte research advances the transformation of gene therapy, life sciences with emerging tech and AI

UNC Charlotte researchers are contributing to pioneering breakthroughs in cancer therapeutics, communicable disease forecasting and prevention, optical applications for health care, and use of AI and other innovative computational tools — and more.

Iktos Secures Prestigious EIC Accelerator Grant to Advance its Automated AI and Robotics Platform for Drug Discovery

Iktos, a global leader in AI-driven drug discovery, has secured a prestigious €2.5 million grant from the European Innovation Council (EIC) Accelerator to advance its AI and robotics synthesis automation technology.

Capgemini's AI Breakthrough to Accelerate Bioeconomy

This new approach, powered by a specialised protein large language model, predicts the most effective protein variants while using 99% less data than traditional methods.

The various challenges associated with AI-driven genetic testing

AI-driven genomics startups leverage technology to analyze genetic data, predict predispositions, and offer personalized health recommendations.

With generative AI, chemists quickly calculate 3D genomic structures

Every cell in your body contains the same genetic sequence, yet each cell expresses only a subset of those genes. These cell-specific gene expression patterns, which ensure that a brain cell is different from a skin cell,

AI Framework Transforms Protein Editing for Breakthroughs

Researchers from Zhejiang University and HKUST (Guangzhou) have developed a cutting-edge AI model, ProtET, that leverages multi-modal learning to

Tevogen Bio and Microsoft expand AI collaboration to PredicTcell tech

Tevogen Bio has expanded its partnership with Microsoft, aiming to further its AI-centred collaboration and advance its predictive precision T-cell targeting technology, PredicTcell.